Literature DB >> 16035949

Cross-reactive protection against influenza A virus by a topically applied DNA vaccine encoding M gene with adjuvant.

Tomomi Ozaki1, Masaomi Yauchi, Ke-Qin Xin, Fumiki Hirahara, Kenji Okuda.   

Abstract

The skin is rich with immunocompetent cells and therefore immunization through the skin is an attractive alternative to the invasive vaccination methods currently used. In this study the backs of mice were gently shaved, hydrated, and painted with a DNA vaccine encoding influenza M protein with adjuvant. The immunized mice were then challenged with two mouse-adapted strains of the influenza virus A: A/PR/8/34 (H1N1) and A/Udorn/72 (H3N2). This adjuvanated and topically applied DNA vaccine efficiently induced cytotoxic as well as humoral immune response and provide cross-reactive protection against several strains of influenza A virus. For better protection against virus infection, it will be necessary to select and combine the DNA vaccine with an appropriate adjuvant.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16035949     DOI: 10.1089/vim.2005.18.373

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  2 in total

1.  Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1.

Authors:  Oleg P Zhirnov; Elena I Isaeva; Tatyana E Konakova; Galini Thoidis; Lyudmila M Piskareva; Irina I Akopova; Alex Kartashov; Anatoly D Altstein; Petr O Ilyinskii; Alexander M Shneider
Journal:  Influenza Other Respir Viruses       Date:  2007-03       Impact factor: 4.380

Review 2.  Transcutaneous antigen delivery system.

Authors:  Mi-Young Lee; Meong-Cheol Shin; Victor C Yang
Journal:  BMB Rep       Date:  2013-01       Impact factor: 4.778

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.